IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1957 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH ARTICLE

Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence

Mistry Suresh D, Trivedi Hiren R, Parmar Dinesh M, Dalvi Prashant S, Jiyo Chacko

Year : 2011| Volume: 43| Issue : 2 | Page no: 183-186

   This article has been cited by
 
1 Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers
Muzamil Khawaja, Janki Thakker, Riyad Kherallah, Masafumi Kitakaze, Hani Jneid, Dominick J. Angiolillo, Yochai Birnbaum
Cardiovascular Drugs and Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
Kelly Bleasby, Robert Houle, Michael Hafey, Meihong Lin, Jingjing Guo, Bing Lu, Rosa I. Sanchez, Kerry L. Fillgrove
Viruses. 2021; 13(8): 1566
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy, Safety, and Tolerability of Pantoprazole Magnesium in the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease (GERD): A Prospective, Multicenter, Post-Marketing Observational Study
José María Remes-Troche,Sergio Sobrino-Cossío,Julio César Soto-Pérez,Oscar Teramoto-Matsubara,Miguel Morales-Arámbula,Antonio Orozco-Gamiz,José Luis Tamayo de la Cuesta,Gualberto Mateos
Clinical Drug Investigation. 2013;
[Pubmed]  [Google Scholar] [DOI]
4 ADP-Receptor Inhibitors in the Perioperative Period: The Good, the Bad, and the Ugly
Adriana Dana Oprea,Wanda M. Popescu
Journal of Cardiothoracic and Vascular Anesthesia. 2013; 27(4): 779
[Pubmed]  [Google Scholar] [DOI]
5 Recent Safety Concerns With Proton Pump Inhibitors
Joan Chen,Yuhong Cathy Yuan,Grigorios I. Leontiadis,Colin W. Howden
Journal of Clinical Gastroenterology. 2012; 46(2): 93
[Pubmed]  [Google Scholar] [DOI]
6 Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors
Chun Shing Kwok,Yoon Kong Loke
Expert Opinion on Drug Safety. 2012; 11(2): 275
[Pubmed]  [Google Scholar] [DOI]
7 The risks of PPI therapy
Paul Moayyedi,Grigorios I. Leontiadis
Nature Reviews Gastroenterology & Hepatology. 2012; 9(3): 132
[Pubmed]  [Google Scholar] [DOI]
8 Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors
Kwok, C.S., Loke, Y.K.
Expert Opinion on Drug Safety. 2012; 11(2): 275-284
[Pubmed]  [Google Scholar]
9 The risks of PPI therapy
Moayyedi, P., Leontiadis, G.I.
Nature Reviews Gastroenterology and Hepatology. 2012; 9(3): 132-139
[Pubmed]  [Google Scholar]
10 Recent safety concerns with proton pump inhibitors
Chen, J., Yuan, Y.C., Leontiadis, G.I., Howden, C.W.
Journal of Clinical Gastroenterology. 2012; 46(2): 93-114
[Pubmed]  [Google Scholar]
11 Anti-platelet therapy for acute coronary syndrome: A review of currently available agents and what the future holds
Syed, F.A., Bett, J.H.N., Walters, D.L.
Cardiovascular and Hematological Disorders - Drug Targets. 2011; 11(2): 79-86
[Pubmed]  [Google Scholar]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow